Research Article

Antimicrobial Potential of Streptomyces spp. Isolated from the Rift Valley Regions of Ethiopia

Table 3

The antimicrobial activity (mm) of the isolates against bacterial pathogens during secondary screening.

S.No.Test pathogens
Isolates codeGram-negative bacteriaGram-positive bacteriaFungi
EcKpPaSt1St2SaSeA. niger

1RVE00219 ± 0.6i12 ± 0.0de16 ± 0.6g15 ± 0.0fg12 ± 0.6ef22 ± 0.0g19 ± 1.0k22 ± 1.2j
2RVE0045 ± 0.0b0 ± 0.0a18 ± 1.2f13 ± 1.2de0 ± 0.0a9 ± 1.0cd8 ± 0.0bc17 ± 0.6h
3RVE0290 ± 0.0a10 ± 0.6cd14 ± 0.0c7 ± 0.0b12 ± 0.6ef17 ± 0.0f24 ± 0.6l16 ± 0.0h
4RVE07717 ± 0.0h12 ± 0.6de9 ± 0.0b15 ± 0.6fg18 ± 0.6h14 ± 1.2e0 ± 0.0a9 ± 0.0ef
5RVE11615 ± 1.2g14 ± 0.0f16 ± 0.0de6 ± 2. 3b0 ± 0.0a7 ± 0.0 c9 ± 0.0cd8 ± 0.0ef
6RVE1187 ± 0.0c9 ± 1.0c14 ± 0.6c11 ± 0.0cd12 ± 0.6ef17 ± 0.0 f17 ± 1.0j5 ± 0.0b
7RVE12519 ± 0.0i14 ± 0.0f9 ± 0.6b11 ± 0.0cd9 ± 0.6c21 ± 0.6g14 ± 0.0gh9 ± 0.0ef
8RVE12921 ± 0.6jk25 ± 0.0j20 ± 0.0h18 ± 0.0gh18 ± 0.0h27 ± 0.0i22 ± 0.0l22 ± 0.6j
9RVE1330 ± 0.0a17 ± 1.0g20 ± 0.0h17 ± 0.6gh0 ± 0.0a12 ± 1.2cd10 ± 0.6cd12 ± 0.6g
10RVE1440 ± 0.0a10 ± 1.0cd9 ± 0.0b0 ± 0.0a0 ± 0.0a15 ± 1.0 f16 ± 1.0h16 ± 0.3h
11RVE16512 ± 0.0de17 ± 0.6g16 ± 0.6de11 ± 0.0cd14 ± 0.6fg11 ± 0.0cd14 ± 0.0g10 ± 1.2g
12RVE1720 ± 0.0a10 ± 0.0cd14 ± 0.6c0 ± 0.0a0 ± 0.0a19 ± 0.0g19 ± 1.0j5 ± 0.0b
13RVE18725 ± 0.6l27 ± 0.0k22 ± 0.0h20 ± 1.2i21 ± 0.0i25 ± 1.2h25 ± 0.6l16 ± 0.3h
14RVE19322 ± 1.2k15 ± 1.0fg18 ± 0.0f8 ± 0.0c9 ± 0.6c11 ± 0.6cd13 ± 0.0f9 ± 0.6ef
15RVE19415 ± 1.2g13 ± 0.0f15 ± 1.2cd20 ± 0.6i21 ± 0.6i12 ± 1.0e19 ± 1.0j17 ± 1.2i
16RVE2147 ± 0.6c11 ± 0.6de14 ± 0.6c7 ± 0.6b14 ± 0.0fg5 ± 1.0b11 ± 1.0e17 ± 0.6i
17RVE21719 ± 0.0i25 ± 0.6j18 ± 0.6f22 ± 1.2j18 ± 0.0h26 ± 0.6i25 ± 0.0l16 ± 0.0h
18RVE21913 ± 0.0ef8 ± 0.6c14 ± 1.0c8 ± 2.3c8 ± 0.6b7 ± 0.6b15 ± 0.6h18 ± 0.0i
19RVE22613 ± 0.6ef8 ± 1.0c9 ± 1.2b0 ± 0.0a11 ± 0.6cde5 ± 1.0b0 ± 0.0a11 ± 0.3g
20RVE22720 ± 0.0jk22 ± 0.0i18 ± 0.6f15 ± 0.0fg18 ± 0.6h15 ± 1.2f10 ± 0.6cd5 ± 0.0b
21RVE23414 ± 0.6g15 ± 0.0fg17 ± 0.6d18 ± 0.6gh18 ± 0.0h21 ± 0.6g22 ± 0.0k10 ± 0.0fg
22RVE23917 ± 0.0h16 ± 1.0g15 ± 0.0cd20 ± 0.0i14 ± 0.6fg15 ± 0f18 ± 0.0i9 ± 0.0ef
23RVE24712 ± 0.6de14 ± 0.6f8 ± 0.0b10 ± 0.0c14 ± 0.6fg15 ± 0.6f16 ± 1.0h11 ± 1.2g
24RVE24811 ± 1.2cd14 ± 0.0f12 ± 0.6de10 ± 1.2c9 ± 0.6c17 ± 1.2h15 ± 0.6h16 ± 0.0h
Control drug28 ± 0.58m25 ± 0.8j24 ± 0.58i29 ± 0.58k28 ± 0.3j25 ± 0.58h25 ± 0.8l29 ± 0.6k
Negative control0 ± 0.0a0 ± 0.0a0 ± 0.0a0 ± 0.0a0 ± 0.0a0 ± 0.0a0 ± 0.0a0 ± 0.0a

Note: Sa: Staphylococcus aureus; Se: Staphylococcus epidermidis; St1: Salmonella typhi ATCC-13311; Kp: Klebsiella pneumoniae; Ec: Escherichia coli; St2: Salmonella typhi ATCC-14028; Pa: Pseudomonas aeruginosa. Mean values sharing the same superscripts within a column are not significantly different at ; inhibition zone diameters are expressed as mean ± SD of the three replications.